CR-3394

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameCR-3394
Drug Alias Namedual NMDA receptor antagonist/IL-6 release inhibitors (Rottapharm Madaus)CR-3991CR-3394
ClassificationSmall molecules
Mechanisms of ActionGlutamate [NMDA] receptor antagonistsIL-6 receptor antagonists
TargetsGlutamate [NMDA] receptorIL-6 receptor
Therapy Area/IndicationsCognition DisordersDepressionAlzheimer Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRottapharm Madaus Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRottapharm Madaus Gmbh
Active IndicationsN/A
Inactive IndicationsCognition DisordersDepressionAlzheimer Disease +[4] 

Other Information

ATC CodeN/A
Related LinksN/A